Authors: Dr. Meena Verma, Mr. Ankit Rao
ABSTRACT: Digital health technologies are reshaping the field of pharmacovigilance, introducing advanced tools for detecting, reporting, and preventing adverse drug reactions (ADRs). With the rise of electronic health records (EHRs), mobile health applications, wearable devices, artificial intelligence (AI), and big data analytics, pharmacovigilance is shifting from reactive safety monitoring to proactive, predictive approaches. This paper examines the impact of digital health innovations on pharmacovigilance systems, focusing on benefits, challenges, regulatory considerations, and future directions. It highlights how digital tools enhance patient safety, regulatory compliance, and global collaboration in drug safety monitoring.
KEYWORDS: Digital Health, Pharmacovigilance, Artificial Intelligence, Electronic Health Records, Drug Safety
Full Issue
| View or download the full issue | PDF 144-149 |